SCHEMBL19866497

SCHEMBL19866497

Clc1cc2c3ccc(-c4ccc5c(c4)[nH]c4c6oc7ccccc7c6cc(Cl)c54)cc3oc2c2c1[nH]c1ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHR P35869 4/20 0.42
▸ MAP3K11 Q16584 2/20 0.39
▸ MAP3K9 P80192 1/20 0.39
▸ CDK5 Q00535 3/20 0.37
▸ CDK5R1 Q15078 2/20 0.37
▸ DYRK1A Q13627 2/20 0.37
▸ GSK3A P49840 1/20 0.37
▸ GSK3B P49841 1/20 0.37
▸ CDK4 P11802 3/20 0.36
▸ CCND1 P24385 3/20 0.36
▸ CAMK2B Q13554 3/20 0.36
▸ CAMK2G Q13555 3/20 0.36
▸ CAMK2D Q13557 3/20 0.36
▸ CAMK2A Q9UQM7 3/20 0.36
▸ CCNE2 O96020 2/20 0.36
▸ CCNE1 P24864 2/20 0.36
▸ CDK2 P24941 2/20 0.36
▸ KMT2A Q03164 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18594338 0.87 AHR (0.54) AHRMAP3K11MAP3K9CDK5CDK5R1
SCHEMBL18593650 0.86 AHR (0.55) AHRMAP3K11MAP3K9CDK5CDK5R1
SCHEMBL19866498 0.77 MAP3K11 (0.34) MAP3K11MAP3K9CDK5CDK5R1DYRK1A
SCHEMBL25435405 0.73 AHR (0.50) AHRKMT2AMEN1HCRTR1CYP1A2
SCHEMBL27142939 0.73 IDO1 (0.42) AHRMAP3K11MAP3K9CDK5CDK5R1
SCHEMBL17451755 0.72 GABRP (0.44) MAP3K11MAP3K9CDK5CDK5R1DYRK1A
SCHEMBL18593681 0.72 AHR (0.51) AHRRAB9AL3MBTL1CYP1A2KDM4E
SCHEMBL25681420 0.72 MAP3K11 (0.45) AHRMAP3K11MAP3K9CDK5CDK5R1
SCHEMBL24519133 0.72 HPGD (0.45) AHRMAP3K11MAP3K9CDK5CDK5R1
SCHEMBL17524700 0.72 MEN1 (0.53) AHRMAP3K11MAP3K9CDK5CDK5R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-03-12 — — US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 AHR 27/4885MAP3K11 3863/4885MAP3K9 3934/4885
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 AHR 27/4885MAP3K11 3863/4885MAP3K9 3934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback